EDC-MixRisk was represented by Dr. Mattias Öberg (Karolinska Institutet/Swetox) at the WHO Chemical Risk Assessment Network meeting that was organized in Parma, Italy 20-22 June 2017. The meeting, hosted by the European Food Safety Authority (EFSA), assembled 83 top organizations within the field of chemical risk assessment from all regions world wide. Development of a […]
EDC-MixRisk will organize a workshop in Brussels, 25-26 September 2017. The aim of the workshop is to discuss the Adverse Outcome Pathway (AOP) approach and to explore the approach from the EDC-MixRisk perspective. The second day of the workshop will focus especially on aspects of societal impact and building key messages based on recent research […]
The EDC-MixRisk Consortium came together for its annual meeting in Stockholm, 15-17 May, to discuss the project’s progress and future activities. The meeting was organized as a three-day event, combining an 1) Adverse Outcome Pathway (AOP) workshop 2) a joint meeting between EDC-MixRisk and EDC-2020 to present scientific results and 3) one and half days […]
2nd International Fresenius MIXTOX Conference “Toxicity of Chemical Mixtures: Risk, Hazard and Exposure Assessment” will be organized in Cologne, Germany 8‐9 June 2017. Prof. Åke Bergman, EDC-MixRisk Coordinator, will give some insights and provide an overview of EDC-MixRisk at the conference. The title of his talk is EDC-MixRisk – a novel approach for assessing EDCs. […]
9th Copenhagen Workshop on Endocrine Disrupters – COW2017 will take place May 2-5, 2017 In Copenhagen, Denmark. The scientific programme will focus on reproduction and child health, which are both fundamental aspects of human health and more relevant than ever. Several EDC-MixRisk researchers will participate in the workshop and present results of their research.
The annual Consortium meeting will be organized in Stockholm, 15-17 May 2017. The first day of the meeting will focus on presenting some of the key results of EDC-MixRisk project as well as of EDC-2020 project. Also a workshop on Adverse Outcome Pathways will take place in the context of the meeting. The following days […]